生物晶片市场－2025-2030年预测

预计生物晶片市场将从 2025 年的 145.9 亿美元成长到 2030 年的 262.92 亿美元，复合年增长率为 12.50%。

生物晶片市场正经历显着成长，这主要得益于技术进步，使得在紧凑型微阵列平台上能够进行快速并行的生物实验。与电子晶片不同，生物晶片是一种非电子设备，其中包含数百万个生物感测器，用于检测酵素、蛋白质、DNA 和抗体等分析物。这些微反应器可应用于疾病诊断、药物研发、基因组学、蛋白质组学和农业等领域，并具备追踪、医疗感测（例如血压、血糖值和血氧水平）和个人化医疗等特殊功能。由于危及生命的疾病发生率不断上升、人口老化导致癌症等疾病风险增加，以及对个人化医疗解决方案的需求日益增长，预计到 2023 年及以后，该市场将持续增长。

关键成长要素包括全球医疗费用支出不断增长以及政府对生技研发投入的增加。这些投资推动了生物晶片技术的进步，提高了其准确性和在各个领域的适用性。慢性病的快速成长以及对快速诊断的需求进一步推动了市场需求，尤其是对DNA晶片、蛋白质晶片和实验室晶片系统的需求。生物技术公司、製药公司、医院、诊断中心和学术机构是主要的终端用户，他们利用生物晶片进行创新研究和患者照护。然而，高成本、消费者认知度低以及对生物数据使用的隐私担忧等挑战制约着市场发展。持续的教育工作和强有力的资料保护措施对于克服这些障碍和维持市场成长至关重要。

从区域来看，北美和欧洲凭藉其先进的医疗基础设施和大规模研发投入，在市场主导。同时，亚太地区正经历快速扩张，这得益于医疗费用支出的成长和慢性病的盛行率上升。随着人们健康意识的提高和基础建设的完善，中东和非洲以及南美洲也展现出新的发展潜力。区域法规结构影响市场动态，已开发市场严格的标准虽然确保了产品安全，但也增加了合规成本。

市场细分重点关注晶片类型（DNA晶片、蛋白质晶片、实验室晶片等）、应用领域（药物研发、疾病诊断、基因组学、蛋白质组学、农业等）以及最终用户（生物技术/製药公司、医院、研究机构等）。竞争分析强调了主要参与者对创新的重视，近期达成的交易和投资增强了产品系列。各公司正优先发展先进的感测器技术和可扩展的生产能力，以满足不断增长的需求。基于产业报告和相关人员的市场洞察，运用包括生命週期分析和数据三角验证在内的综合调查方法预测市场趋势。图表等视觉化工具有助于相关人员更好地理解市场动态。

受技术进步、医疗需求成长和应用领域不断拓展的推动，生物晶片市场预计将在2023年至2025年间实现强劲成长。解决成本壁垒、公众认知不足和隐私顾虑等问题，对于充分发挥市场潜力至关重要，这将使生物晶片成为现代生物技术和个人化医疗的基石。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

• 历史资料（2022-2024 年）和预测资料（2025-2030 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

第五章 生物晶片市场（按类型划分）

• 介绍
• DNA晶片
• 蛋白质晶片
• 实验室晶片
• 基于细胞和组织晶片

第六章 生物晶片市场依应用领域划分

• 介绍
• 药物发现与开发
• 疾病诊断
• 基因组学
• 蛋白质体学
• 农业
• 环境测试
• 其他的

第七章 以最终用户分類的生物晶片市场

• 介绍
• 生物技术和製药业
• 医院和诊断中心
• 学术和研究机构
• 合约研究组织 (CRO)，政府研究实验室

第八章 生物晶片市场（按地区划分）

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 韩国
  • 台湾
  • 其他的

第九章：竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第十章：公司简介

• Abbott Laboratories
• Revvity, Inc.
• Standard BioTools Inc.
• Randox Laboratories
• Thermo Fisher Scientific
• Bio Rad Laboratories
• Illumina Inc.
• Agilent Technologies
• GE Healthacre
• Cepheid Inc,
• F. Hoffmann-La Roche AG

第十一章 分析方法

The Biochips Market is set to expand from USD 14.590 billion in 2025 to USD 26.292 billion by 2030, with a 12.50% compound annual growth rate (CAGR).

The biochips market is witnessing significant growth, driven by the technology's ability to perform rapid, simultaneous biological experiments on a compact microarray platform. Unlike electronic microchips, biochips are non-electronic devices equipped with millions of biosensors that detect analytes such as enzymes, proteins, DNA, or antibodies. These microreactors enable applications like disease diagnostics, drug discovery, genomics, proteomics, and agriculture, as well as specialized functions such as tracking, medical sensing (e.g., BP, glucose, oxygen), and personalized medicine. Since 2023, the market has been propelled by rising incidences of life-threatening disorders, an aging population susceptible to conditions like cancer, and increasing demand for tailored healthcare solutions.

Key growth drivers include expanding global healthcare expenditure and heightened government funding for biotechnology R&D. These investments support advancements in biochip technologies, enhancing their precision and applicability across diverse fields. The surge in chronic diseases and the need for rapid diagnostics further boost demand, particularly for DNA chips, protein chips, and lab-on-chip systems. Biotechnology and pharmaceutical companies, hospitals, diagnostic centers, and academic institutes are key end-users, leveraging biochips for innovative research and patient care. However, challenges such as high costs, limited consumer awareness, and privacy concerns related to biological data usage pose restraints. These hurdles necessitate ongoing education and robust data protection measures to sustain market growth.

Geographically, North America and Europe lead due to advanced healthcare infrastructures and significant R&D investments, while Asia-Pacific is experiencing rapid expansion driven by increasing healthcare spending and rising prevalence of chronic diseases. The Middle East, Africa, and South America show emerging potential as awareness and infrastructure develop. Regional regulatory frameworks influence market dynamics, with stringent standards in developed markets ensuring product safety but increasing compliance costs.

Market segmentation highlights types (DNA chips, protein chips, lab-on-chip, others), applications (drug discovery, disease diagnostics, genomics, proteomics, agriculture, others), and end-users (biotech/pharma, hospitals, research institutes, others). Competitive analysis underscores major players' focus on innovation, with recent deals and investments enhancing product portfolios. Companies are prioritizing advanced sensor technologies and scalable manufacturing to meet growing demand. Market insights, derived from industry reports and stakeholder inputs, utilize comprehensive methodologies, including lifecycle analysis and data triangulation, to forecast trends. Visual aids like charts enhance stakeholder understanding of market dynamics.

From 2023 to 2025, the biochips market is poised for robust growth, fueled by technological advancements, rising healthcare needs, and expanding applications. Addressing cost barriers, awareness gaps, and privacy concerns will be critical to unlocking the market's full potential, positioning biochips as a cornerstone of modern biotechnology and personalized medicine.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Type

• DNA Chip
• Protein Chip
• Lab-on-Chip
• Cell-Based & Tissue Chips

By Application

• Drug Discovery and Development
• Disease Diagnostics
• Genomics
• Proteomics
• Agriculture
• Environmental Testing
• Others

By End-User

• Biotech & Pharma
• Hospitals & Diagnostics Centers
• Academic & Research Institutes
• CROs & Government Labs

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East & Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. BIOCHIPS MARKET BY TYPE

• 5.1. Introduction
• 5.2. DNA Chip
• 5.3. Protein Chip
• 5.4. Lab-on-Chip
• 5.5. Cell-Based & Tissue Chips

6. BIOCHIPS MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Drug Discovery and Development
• 6.3. Disease Diagnostics
• 6.4. Genomics
• 6.5. Proteomics
• 6.6. Agriculture
• 6.7. Environmental Testing
• 6.8. Others

7. BIOCHIPS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Biotech & Pharma
• 7.3. Hospitals & Diagnostics Centers
• 7.4. Academic & Research Institutes
• 7.5. CROs & Government Labs

8. BIOCHIPS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Italy
  • 8.4.5. Others
• 8.5. Middle East & Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Taiwan
  • 8.6.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Abbott Laboratories
• 10.2. Revvity, Inc.
• 10.3. Standard BioTools Inc.
• 10.4. Randox Laboratories
• 10.5. Thermo Fisher Scientific
• 10.6. Bio Rad Laboratories
• 10.7. Illumina Inc.
• 10.8. Agilent Technologies
• 10.9. GE Healthacre
• 10.10. Cepheid Inc,
• 10.11. F. Hoffmann-La Roche AG

11. RESEARCH METHODOLOGY